期刊文献+

新疆地区健康成人外周血NK细胞体外扩增技术的研究 被引量:1

The study of NK cells’vitro amplification techniques in Xinjiang health adult blood
下载PDF
导出
摘要 目的探索用免疫磁珠分选高纯度CD3-CD56+CD16+CD19-CD45+NK细胞并研究体外保持NK细胞活性及体外扩增技术。方法应用免疫磁珠阴性分选法(MACS)分离出高纯度的CD3-CD56+CD16+CD19-CD45+NK细胞,置于含10%胎牛血清的RPMI1640培养基中,分别加入500、1 000、6 000U/mL 3种不同浓度的细胞因子IL-2,组成不同培养体系进行体外扩增。采用细胞计数法、流式细胞术免疫表型分析方法,比较3种细胞因子刺激组及对照组培养的NK细胞数量及纯度的变化。结果免疫磁珠阴性分选后所得的高纯度CD3-CD56+CD16+CD19-CD45+NK细胞纯度由分选前的(29.66±2.31)%提高到(95.37±1.93)%,培养7d后,空白对照组NK细胞纯度降低为(61.82±2.58)%,而加入细胞因子IL-2的3组NK细胞纯度均无明显差异(P>0.05)。18d后,空白对照组的NK细胞纯度降低至(4.28±1.56)%,而浓度为6 000U/mL的实验组纯度为(93.72±2.29)%,与加入细胞因子IL-2前比较,差异无统计学意义(P>0.05)。NK细胞中加入3种不同浓度细胞因子IL-2组500、1 000、6 000U/mL未见明显扩增,差异无统计学意义(P>0.05)。结论经免疫磁珠分选法分选获得的NK细胞,在体外使用10%胎牛血清的RPMI1640培养基培养,添加刺激因子IL-2后,可有效提高NK细胞的存活率,为今后NK细胞的研究与免疫治疗提供了一种简单、有效保持NK细胞纯度的方法。 Objective The study aims to sort high purity CD3-CD56+CD19+CD16 CD45-NK cells in vitro, and to keep the activity of NK cells and in vitro amplification technique by means of immune magnetic bead. Methods By using immune magnetic bead negative sorting method (MACS), separate CD3 + CD16q-CD56-CD19+CD45 NK cells with high purity, put them in bovine serum of RPMI1640 medium with 10% fetal, add three different concentration of cell factor IL-2 different training system of in vitro amplification. The cell count method, flow cytometry immune phenotypic analysis method are applied to compare the number of NK cells and the change of purity of three kinds of different concentration cell factors. Results CD3-CD56+CD16+CD19 CD45+NK cells with high purity by Negative immune magnetic beads increase the purity from (29.66±2.31) % to (95.37±1.93) , after 7 dtraining, the purity in blank control group reduces to (61.82±2.58) %, NK cells with three groups of cytokine IL-2 NK have no significant differences (P〉0. 05). After 18 d, the purity in blank control group of NK cells decreases to (4.28±1.56) 0/40, the purity of the group with concentration of 6 000 U/mL is (93.72±2.29) %, and there was no statistically significant difference (P 〉0.05), compared with the cells before adding cytokines IL-2. NK cells with lhree different concentrations of cytokines IL-2 group of 500, 1 000, 6 000 U/mL did not show obvious amplification, so there was no statistically significant difference (P 〉0.05). Conclusion The NK cells with immune magnetic bead sorting method, cultivated in vitro using 10% fetal calf serum RPMI1640 media by adding stimulating factor IL- 2 can effectively improve the survival rate of NK cells. A simple and effective method to keep the purity of NK cells is provided in future for the NK cells and immune therapy.
出处 《新疆医科大学学报》 CAS 2013年第6期763-767,共5页 Journal of Xinjiang Medical University
基金 新疆维吾尔自治区科技支疆项目(201191158)
关键词 NK细胞 Mini&Midi MACS 细胞因子 NK cells Mini&Midi MACS cytokine
  • 相关文献

参考文献15

  • 1Srivastava S, Lundqvist A, Childs RW. Natural killer cell im?munotherapy for cancer: a new hope[J]. Cytotherapy , 2008, 10(8): 775-783.
  • 2Terme M, Ullrich E, Delahaye NF, et al. Natural killer cell?directed therapies: moving from unexpected results to success?ful strategies[J]. Nat Immunol , 2008, 9( 5) : 486-494.
  • 3Frued AG, Yokoham A, Becknell B, et al. Evidence for dis?crete stages of human natural killer cell differentiation in vivo[J]. Exp Med, 2006, 203(4): 1033- 1043.
  • 4Siegler U, Meyer-Menard S,Jorger S. Good manufacturing practice- compliant cell sorting and large-scale expansion of single KIR- positive alloreactive human natural killer cells for multiple infusions to leukemia patients[J]. Cytotherapy , 2010, 12(6) :750-763.
  • 5Huntington ND, Vosshenrich CA, DisantoJP. Developmental path ways that generate natural killer cell diversity in mice and humans[J]. Nat Rev Imrnunol , 2007, 7(9): 703-714.
  • 6杨志刚,曾耀英,何贤辉,王通,江逊,唐德燊.一种分离、培养扩增小鼠NK细胞方法的建立[J].细胞与分子免疫学杂志,2005,21(3):379-381. 被引量:16
  • 7乔文斌,张琰,黄艳春.T淋巴细胞亚群与NK细胞检测在弥漫大B细胞淋巴瘤患者治疗中的意义[J].新疆医科大学学报,2012,35(4):513-516. 被引量:5
  • 8Geller MA, Cooley S,Judson PL, et al. A phase II study of allogeneic natural killer cell therapy to treat patients with re?current ovarian and breast cancer[J]. Cytotherapy , 2011, 13 (1): 98-107.
  • 9Nguyen S, Dhedin N, VernantJP, et al. NK cell reconstitu?tion after haploid den tical hematopoietic stem cell trans?plants: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect[J]. Blood, 2006, 10(5) :4135- 4142.
  • 10Zamai L, Ponti C, Mirandola P, et al. NK cells and cancer[J]. Immunol , 2007, 178(7) :4011-4016.

二级参考文献16

  • 1吴霞,李大金.趋化性细胞因子对NK细胞生物学功能的调控作用[J].细胞与分子免疫学杂志,2004,20(4):504-507. 被引量:3
  • 2陈保成,冀学斌.非霍奇金淋巴瘤的生物学治疗[J].山东医药,2005,45(10):72-73. 被引量:5
  • 3张文书,路名芝,刘勇.弥漫性大B细胞淋巴瘤的研究现状[J].赣南医学院学报,2006,26(1):134-137. 被引量:9
  • 4袁鸿英.NK细胞的抗肿瘤作用[J].国外医学:肿瘤学分册,1985,2:82-85.
  • 5Brennan J, Mager D, Jefferies W, et al. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties[J]. J Exp Med, 1994, 180(12): 2287-2295.
  • 6Gunji Y, Vujanovic NL, Hiserodt JC, et al. Generation and characterization of purified adherent lymphokine-activated killer cells in mice[J]. J Immunol, 1989, 142(4): 1748- 1796.
  • 7Peritt D, Robertson S, Gri G, et al. Differentiation of human NK cells into NK1 and NK2 subsets[J]. J Immunol, 1999, 161(11):5821 -5824.
  • 8Miller JS, Klingsporn S, Lurd J, et al. Large scale ex vivo expansion and activation of human natural killer cells for autologous therapy[J].Bone Marrow Transplant, 1994, 14(4): 555 -562.
  • 9Farag SS, Van-Deusen JB, Fehniger TA, et al. Biology and clinical impact of human natural killer cells[J]. Int J Hematol, 2003, 78(1) :7-17.
  • 10古力克孜.吾守尔,杨顺娥,闻淑娟.吉西他滨联合奥沙利铂和地塞米松治疗复发或难治性非霍奇金淋巴瘤[J].新疆医科大学学报,2009,32(8):1037-1040. 被引量:13

共引文献19

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部